Search General Info
Search Education
Search Partnering Companies

Christophe Bourdon

Vienna, Austria
Christophe Bourdon is the vice president and general manager for the U.S. Oncology Business at Amgen, with ten marketed portfolios totaling to one of Amgen’s largest individual businesses. During his 25 years in the pharmaceutical industry, his focus has been to build strong & diverse teams, to foster an environment focused on innovation and curiosity with one constant driver in mind: Making a meaningful difference for patients.
Today, Amgen is advancing a deep and diverse Oncology pipeline, Christophe and his team are committed to quickly bringing the next frontier of innovation in Oncology to cancer patients and their families.
Before coming back to Amgen in 2018 to assume his current role, he was the senior vice president, EMEAC at Alexion, leading the commercial development of ultra-orphan therapies across 40 countries, including innovative product launches within major markets. Prior to Alexion, Christophe held a series of leadership roles at Amgen with increasing responsibility, including executive director of the France Oncology Business Unit, general manager of Central Eastern Europe, and vice president and general manager for Germany.

Christophe earned his MBA from the International Institute for Management Development (IMD), Lausanne, Switzerland and a BA from the Institut Superieur de Gestion, Paris France. He holds French/German dual citizenships. He has also lived, led teams and businesses across Europe and Japan. He moved to the United States in 2018 with his husband and now resides in Los Angeles, they are excited about discovering the US.
Speaking In
8:30 AM - 9:55 AM (PDT)
Tuesday, June 9
The Covid-19 pandemic is creating unprecedented healthcare challenges with far reaching effects yet…